Borviz 3.5 Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Bortezomib (3.5mg)
Overview Borviz 3.5 Injection
Bortezomib 3.5 mg Injection treats multiple myeloma and mantle cell lymphoma by inhibiting or reducing cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; improper use can lead to severe adverse reactions. Therapeutic effects might not be immediately apparent, requiring weeks or months; discontinue only under medical guidance. Common side effects include fatigue, nausea, vomiting, and anorexia. Increased fluid intake is often recommended. Avoid driving or operating machinery due to potential drowsiness and dizziness. This medication can lower blood cell counts (red and white), increasing infection risk; regular blood tests monitoring blood cell levels, along with heart, liver function, and uric acid, are crucial. Consult your doctor before use if you have liver, kidney, heart disease, or bleeding disorders. Report any cognitive changes, such as memory impairment or difficulty concentrating. Inform your healthcare provider of all medications you are taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners during treatment.
Uses of Borviz 3.5 Injection
Myeloma and mantle cell lymphoma
Major Benefits of Borviz 3.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Borviz 3.5 Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Borviz 3.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Borviz 3.5 Injection works:
Borviz 3.5 Injection is an anticancer agent that inhibits the cellular degradation of proteins. This protein accumulation within cancer cells ultimately triggers their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Borviz 3.5 Injection and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Borviz 3.5 Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might exceptionally prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administering Borviz 3.5 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Borviz 3.5 Injection may induce adverse reactions impacting driving capabilities. These reactions can include fatigue, vertigo, syncope, or visual disturbances, potentially hindering safe driving.
KidneyCAUTION
Exercise caution when administering Borviz 3.5 Injection to individuals with advanced renal impairment. Dosage modification of Borviz 3.5 Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should receive Borviz 3.5 Injection with close monitoring. Dosage modification for Borviz 3.5 Injection might be necessary. Physician consultation is advised.
What if you forget to take Borviz 3.5 Injection :
Omit a Borviz 3.5 Injection dose? Seek medical advice immediately.
Facts to Know About Borviz 3.5 Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylalanine-based Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently